Answer
Sep 18, 2024 - 10:22 AM
Do you have the same question? Follow this Question
Sep 18, 2024 - 10:22 AM
We’ve provided several answers to questions related to Multaq (Dronedarone) , see some other helpful Q&A related to this product.
Question: What is the success rate of Multaq?
Answer: Approximately 62.3% of patients treated with Multaq experienced no recurrence of atrial fibrillation (AFib) symptoms at the end of the first year of treatment. This success rate highlights the effectiveness of Multaq in managing AFib.
Question: Is Multaq safe for pregnant or breastfeeding women?
Answer: Multaq is not recommended for pregnant or breastfeeding women as it may harm the unborn baby or pass through breast milk and affect the nursing child.
Question: What is the protein binding percentage of Multaq?
Answer: The protein binding percentage of Multaq is more than 98%. High protein binding can influence the drug's distribution in the body and its interaction with other medications.